Abelacimab information

Abelacimab
Monoclonal antibody
Type	Whole antibody
Target	Factor XI and its active form Factor XIa
Clinical data
Other names	MAA868
AHFS/Drugs.com	Monograph
License data	US DailyMed: Abelacimab; US FDA: Abelacimab;
Routes of; administration	Intravenous
Legal status
Legal status	Investigational;
Identifiers
CAS Number	1610943-06-0;
ChemSpider	none;
KEGG	D10821 ;

Abelacimab (MAA868), is a fully human monoclonal antibody for the treatment of coagulation,^[1] under development by Anthos Therapeutics.

^ Cite error: The named reference Verhamme2021 was invoked but never defined (see the help page).

and 3 Related for: Abelacimab information